CA2006106A1 - Des compositions pharmaceutiques ameliorees pour l'allegement des affections des dents, microencapsulees et presentant de meilleures qualites de separation de phase - Google Patents

Des compositions pharmaceutiques ameliorees pour l'allegement des affections des dents, microencapsulees et presentant de meilleures qualites de separation de phase

Info

Publication number
CA2006106A1
CA2006106A1 CA2006106A CA2006106A CA2006106A1 CA 2006106 A1 CA2006106 A1 CA 2006106A1 CA 2006106 A CA2006106 A CA 2006106A CA 2006106 A CA2006106 A CA 2006106A CA 2006106 A1 CA2006106 A1 CA 2006106A1
Authority
CA
Canada
Prior art keywords
pocket
dental disease
pharmaceutical compositions
phase separation
compositions useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2006106A
Other languages
English (en)
Other versions
CA2006106C (fr
Inventor
Michael G. Lanzilotti
James R. Lawter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to CA002271571A priority Critical patent/CA2271571C/fr
Publication of CA2006106A1 publication Critical patent/CA2006106A1/fr
Application granted granted Critical
Publication of CA2006106C publication Critical patent/CA2006106C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
CA002006106A 1988-12-22 1989-12-20 Des compositions pharmaceutiques ameliorees pour l'allegement des affections des dents, microencapsulees et presentant de meilleures qualites de separation de phase Expired - Lifetime CA2006106C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002271571A CA2271571C (fr) 1988-12-22 1989-12-20 Des compositions pharmaceutiques ameliorees pour l'allegement des affections des dents, microencapsulees et presentant de meilleures qualites de separation de phase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28873988A 1988-12-22 1988-12-22
US07/288,739 1988-12-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002271571A Division CA2271571C (fr) 1988-12-22 1989-12-20 Des compositions pharmaceutiques ameliorees pour l'allegement des affections des dents, microencapsulees et presentant de meilleures qualites de separation de phase

Publications (2)

Publication Number Publication Date
CA2006106A1 true CA2006106A1 (fr) 1990-06-22
CA2006106C CA2006106C (fr) 1999-10-26

Family

ID=23108436

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002006106A Expired - Lifetime CA2006106C (fr) 1988-12-22 1989-12-20 Des compositions pharmaceutiques ameliorees pour l'allegement des affections des dents, microencapsulees et presentant de meilleures qualites de separation de phase

Country Status (15)

Country Link
EP (1) EP0374532B1 (fr)
JP (1) JP2901673B2 (fr)
AR (1) AR243768A1 (fr)
AT (1) ATE111729T1 (fr)
AU (1) AU635913B2 (fr)
CA (1) CA2006106C (fr)
DE (1) DE68918419T2 (fr)
DK (1) DK175150B1 (fr)
ES (1) ES2059683T3 (fr)
HK (1) HK1000314A1 (fr)
IE (1) IE65813B1 (fr)
IL (1) IL92699A (fr)
NZ (1) NZ231792A (fr)
PT (1) PT92618B (fr)
ZA (1) ZA899863B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE105177T1 (de) * 1988-12-22 1994-05-15 American Cyanamid Co Verfahren zur behandlung von periodontitis durch protrahierte wirkstoffabgabe von arzneimitteln in der zahnhoehle, zusammensetzung davon und vorrichtung zur verabreichung.
AU2004318602B2 (en) * 2003-12-19 2009-12-10 The University Of North Carolina At Chapel Hill Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
JP6376850B2 (ja) * 2014-06-06 2018-08-22 株式会社ファンケル 表面処理剤
WO2017039435A1 (fr) * 2015-08-28 2017-03-09 Rijksuniversiteit Groningen Moyens et procédés de libération prolongée d'oxygène in situ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US5000886A (en) * 1987-05-26 1991-03-19 American Cyanamid Company Silicone-hardened pharmaceutical microcapsules and process of making the same
ATE105177T1 (de) * 1988-12-22 1994-05-15 American Cyanamid Co Verfahren zur behandlung von periodontitis durch protrahierte wirkstoffabgabe von arzneimitteln in der zahnhoehle, zusammensetzung davon und vorrichtung zur verabreichung.

Also Published As

Publication number Publication date
IE894146L (en) 1990-06-22
DK655989D0 (da) 1989-12-21
HK1000314A1 (en) 1998-02-27
DE68918419D1 (de) 1994-10-27
PT92618B (pt) 1995-09-12
NZ231792A (en) 1992-04-28
AU4707889A (en) 1990-06-28
ATE111729T1 (de) 1994-10-15
IE65813B1 (en) 1995-11-15
AU635913B2 (en) 1993-04-08
DK655989A (da) 1990-06-23
EP0374532B1 (fr) 1994-09-21
JP2901673B2 (ja) 1999-06-07
ES2059683T3 (es) 1994-11-16
DK175150B1 (da) 2004-06-14
AR243768A1 (es) 1993-09-30
ZA899863B (en) 1990-10-31
EP0374532A2 (fr) 1990-06-27
PT92618A (pt) 1990-06-29
EP0374532A3 (fr) 1991-08-07
IL92699A (en) 1994-08-26
IL92699A0 (en) 1990-09-17
CA2006106C (fr) 1999-10-26
DE68918419T2 (de) 1995-05-04
JPH02212418A (ja) 1990-08-23

Similar Documents

Publication Publication Date Title
KR900009045A (ko) 치아질환 치료용 조성물 및 그 조성물의 투여장치
US5686094A (en) Controlled release formulations for the treatment of xerostomia
US5102666A (en) Calcium polycarbophil controlled release composition and method
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
CA2009593A1 (fr) Medicament contenant de l'acide dihydrolipoique comme ingredient actif
WO2004043351A2 (fr) Timbre oral soluble presentant du collagene et des ingredients actifs reticules
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
JP3064417B2 (ja) 放出制御性製剤及び方法
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
CA2143413A1 (fr) Pellicule liberant un medicament localement pour le traitement periodontique
CA2180178A1 (fr) Utilisation des derives 2,3-diaryl-1-benzopyrane dans la production d'un medicament employe dans le traitement et la prevention de la diminution du volume du tissu osseux et de l'osteoporose
AU1300001A (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
CA2006106A1 (fr) Des compositions pharmaceutiques ameliorees pour l'allegement des affections des dents, microencapsulees et presentant de meilleures qualites de separation de phase
SE8600496D0 (sv) Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
CA2259270A1 (fr) Preparation pharmaceutique contenant du nimesulide pour administration orale
Carroll et al. The histologic effect of topically applied acetylsalicylic acid on bone healing in rats
AU2742395A (en) Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
EP1567102A2 (fr) Timbre oral soluble presentant du collagene et des ingredients actifs reticules
CA2097878A1 (fr) Agent therapeutique pour la neutropenie
JP2002520269A5 (fr)
CA2187153A1 (fr) Formulations pharmaceutiques effervescentes contenant des microgelules biodegradables a liberation controlee
HUP9802896A3 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
IT1270592B (it) Formulazione a rilascio modificato per la somministrazione di farmaci antiinfiammatori non steroidei

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry